Global

‡ In these countries please contact our distributor

DURAFIBER◊

About DURAFIBER

The DURAFIBER range is a new generation of strong non woven gelling fibre dressings with the benefit of clean one piece removal1-6

 

DURAFIBER, half wet, half dryStrength in Performance

The DURAFIBER range is a new generation of high performing gelling fibre dressing designed to meet the many challenges posed by medium and heavily exuding infected and non infected wounds.

Specially designed with innovative fibre technology, DURAFIBER features a unique non-woven fibre blend that is integral to its high performance.

This unique blend provides an exclusive combination of benefits that set DURAFIBER dressings apart from conventional gelling fibre dressings.

Clean One-Piece Removal1-6

DURAFIBER Clean one piece removalHigh Wet Strength and Structural Integrity1-6 

  • Low risk of fibre shed
    and dressing residue3,5
  • Minimal pain and trauma
    for the patient on dressing removal1-6

DURAFIBER Dressings Technology Video

 

Effective Exudate Management

DURAFIBER Locking In Video StillHigh Absorption and Retention Capacity1,2,4,9

  • Minimal lateral wicking – helps protect peri-wound skin against the risk of maceration2,3,5,8,11 
  • Locks in fluid and harmful bacteria – may help prevent the risk of cross contamination on removal1,2,4,7-10,12,13

Lateral Wicking Test Video

This in vitro experiment illustrates the ability of DURAFIBER dressings to lock in absorbed fluid and so control the lateral spread of wound fluid. 1,2,8

Once applied, DURAFIBER rapidly wicks the fluid away from the surface of the petri dish, (representative of exudate in a wound bed). The absorbed fluid does not spread to the outer edges of the dressing but is contained within the area of the simulated wound bed.

The ability of a dressing to control the lateral spread of fluid is important in helping to minimise the risk of peri-wound maceration.

 

Locking In Test Video

This in vitro experiment uses different coloured fluids to illustrate the ability of DURAFIBER dressings to lock in the fluid it absorbs with the result that there is no bleeding of the colours into one another1,2,7.

The ability of a dressing to lock in fluid is important for helping to remove excess fluid and any harmful bacteria it contains away from the wound bed and may reduce the risk of cross contamination on dressing removal.

 


Uncompromised Patient Comfort3,5

DURAFIBER conforming gelGentle Conformable Gel Matrix1,2,5,19  

  • Helps promote patient
    concordance3,5
  • Reduces dead space
    where bacteria may proliferate1,2,12,19,20

Contact Test Video

This in vitro experiment shows how the DURAFIBER dressing rapidly transforms into a soft cohesive gel as it is hydrated with fluid and conforms intimately to the simulated wound bed. The ability of a dressing to maintain close contact with the wound surface without adhering is key in helping to maintain a moist wound environment favourable for healing. It also helps to minimise the risk of pooling; reduce the potential for dead space between the wound and dressing interface and minimise the potential for trauma on dressing removal 1,2,12

 


Assured Dressing Efficiencies

Unique Anti-Shrinkage Properties1,2,4

  • Minimal shrinkage when wet – may help sustained coverage1,2,4
  • Maintains a favourable moist wound healing environment1,18,21

 

Specially Designed with Innovative Technology

The DURAFIBER dressing range has a unique non woven fibre blend that is integral to its high performance.

20%

 Natural strengthening cellulose fibres

+

80%

 Gelling cellulose ethyl sulphonate fibres (CES)

=

100%

 Finely spun matrix that forms a soft cohesive gel on contact with exudate1-6

DURAFIBER animation stillThis unique blend provides an exclusive combination of properties that enables DURAFIBER to meet the many challenges of exuding wounds:

  • High Wet Strength: Cellulose fibres give the dry and gelled matrix in-built structural integrity1-6
  • Excellent Absorbency: Gelling fibres swell and gel on contact with exudate absorbing and locking in fluid1,2,4-6
  • Minimal Shrinkage: Reinforcing fibres retain the dressings shape when wet, minimising shrinkage1,2,4
  • Highly Conformable: Transforms into a soft, cohesive gel sheet which contours closely to the wound bed1-3,5,10,14

DURAFIBER Dressings Product Information

DURAFIBER ALLEVYN Gentle Border Multisite
DURAFIBER ALLEVYN  Gentle Border Multisite

ALLEVYN Dressings - an ideal choice of secondary fixation.28,30


DURAFIBER Ag Dressings

DURAFIBER AgDURAFIBER Ag dressings are effective against infection

Sustained release of silver for up to 7 days (in vitro14,15

Starts to kill pathogens within 30 minutes of contact (shown in vitro vs. Staphylocuccus aureus, Pseudomonas aeruginosa, MRSA and VRE)16

Provides broad spectrum antimicrobial activity at 4 hours against pathogens (shown in vitro vs.

DURAFIBER AgPseudomonas aeruginosa, VRE, Bacteroides fragilisCandida albicans and Rhizopus arrhizus)17

Sustains antimicrobial activity for up to 7 days against a broad spectrum of aerobic, anaerobic bacteria including antibiotic resistant strains (shown in vitro vs. MRSA, VRE, yeasts, filamentous fungi wound pathogens)14,15

DURAFIBER Ag Dressings Product Information

 

References

1 Smith & Nephew Report DS.10.056 R1 05 2010 DURAFIBER Dressing Physical Properties.

2 DS.11.187.DOF Testing Performed as Part of DURAFIBER Photo Shoot.

3 Case Series Evaluation: The Use of DURAFIBER on Exuding Wounds. Wounds UK 2012,Vol 8, No 3.

4 Smith & Nephew Wound Management Laboratory Report Reference DS/10/060/R1, DURAFIBER Ag Dressing Physical Properties, Dowler A, September 2010.

5 Smith & Nephew Wound Management, Data on File Report Reference OR- DOF/28, A prospective, open, multicentre study to evaluate a new fibrous silver dressing in the treatment of moderate to highly exuding chronic wounds, Rafiq G, Fenton S January 2013.

6 Smith & Nephew Wound Management Laboratory Report Reference DS/12/093/DOF, Integrity Testing of DURAFIBER Ag in horse serum and ionic solution, Dowler A, April 2012.

7 Smith & Nephew Wound Management Data on File 10.040.01 April 2010 Visual demonstration of sequestration of Pseudomonas aeruginosa and Staphylococcus aureus in a DURAFIBER dressing using confocal microscopy.

8 Smith & Nephew Report DS.10.042 R1 Report of testing on lateral wicking of DURAFIBER versus AquacelTM and Kaltostat TM dressings.

9 Smith & Nephew Wound Management Laboratory Report Reference DS/12/109/DOF, Testing on Absorption of DURAFIBER Ag versus Aquacel Ag during compression, Dowler A, April 2012.

10 Smith & Nephew Wound Management Laboratory Report Reference DS/12/158/DOF, Sequestration Testing of DURAFIBER Ag, Aquacel Ag and SorbsanTM Silver Flat, Dowler A,June 2012.

11 Smith & Nephew Wound Management Laboratory Report Reference DS/12/108/DOF, Testing on lateral wicking of DURAFIBER Ag versus Aquacel Ag and MaxorbTM Extra Ag dressings, Dowler A, April 2012.

12 Smith & Nephew Research Centre Review Report, The potential for proliferation of bacteria in wound exudate, Report Reference RR-WMP06290-40-01, Woodmansey E, April 2010.

13 Smith & Nephew Wound Management, Data on file report reference 1208007, Visual demonstration of sequestration of Pseudomonas aeruginosa and Staphylococcus aureus in a DURAFIBER Ag dressing using confocal microscopy. Lumb H, August 2012.

14 Smith & Nephew Wound Management, Data on file report reference 1004007, Antimicrobial activity of DURAFIBER Ag and Aquacel Ag against bacteria, yeast and fungi commonly found in wounds over a 7 day period, Woodmansey E, April 2010.

15 Smith & Nephew Wound Management, Data on file report reference 1009012, Antimicrobial activity of DURAFIBER Ag against bacteria, yeast and fungi commonly found in wounds over a 7 day period, Vaughan KL, McMillan J, Lumb H and Woodmansey E, September 2010.

16 Smith & Nephew Wound Management, Data on file report reference 1004009, Assessment of the contact kill activity of DURAFIBER Ag against common wound pathogens, Woodmansey E, April 2010.

17 Smith & Nephew Wound Management, Data on file report reference 1009013, Antimicrobial activity of DURAFIBER Ag against bacteria, yeast and fungi commonly found in wounds over a 4 hour period, Vaughan KL, McMillan J, Lumb H and Woodmansey E, September 2010.

18 World Union of Wound Healing Societies (WUWHS) Principles of best practice. Wound exudate and the role of dressings. A consensus document London MED Ltd. 2007.

19 Smith & Nephew Wound Management Laboratory Report Reference DS/12/143/DOF, Intimate Contact Testing of DURAFIBER Ag, Aquacel Ag and Sorbsan Silver Flat, Dowler A, June 2012.

20 Smith & Nephew Research Centre Review Report RR WMP06290-40-01 The potential for proliferation of bacteria in wound exudate.

21 The Clinical and Physical Properties of DURAFIBER Ag, the Moist Wound Environment and the Autolytic Debridement, Myers D, July 2012.

22 Smith & Nephew Report DS.10.013 R1 02 2010 Aquacel Dressing Physical Properties.

23 Smith & Nephew Wound Management Laboratory Report Reference DS/10/060/R2, Aquacel Ag Dressing Physical Properties.

24 NHS Drug Tariff August 2012 http://www.ppa.org.uk/ppa/edit_intro.htm

25 Unit costs of health and social care, Curtis, L. PSSRU: 2010.

26 Siddiqui AR, Bernstein JM (2010).

27 DURAFIBER Technology video

28 Smith & Nephew Report DS/12/314 R December 2012 Wound Model Testing of DURAFIBER with various secondary dressings

29 DURAFIBER SMTL report 3303 Wound Dressing Testing

30 Smith & Nephew Report Development Services, Analytical Report Reference DS/10/053/R1, Wound Model Testing of DURFAIBER Ag and Aquacel Ag dressings with various secondary dressings, Dowler A, August 2010.

*In comparison with standard Aquacel dressings, excludes Aquacel Ribbon with strengthening fibre and Aquacel Extra

**In comparison with standard Aquacel Ag dressings, excludes Aquacel Ag Ribbon with strengthening fibre and Aquacel Ag Extra

Aquacel is a trademark of Convatec

TM All trademarks acknowledged

Description

DURAFIBERDURAFIBER is a soft sterile non-woven pad or ribbon dressing composed of cellulose ethyl sulphonate fibres.

This highly absorbent and conformable dressing is designed to rapidly form a clear, cool gel on contact with wound fluid. This gel absorbs excess fluid, locks exudate away from the wound, provides a moist environment to support autolytic debridement and conforms intimately to the wound bed.

The high integral wet strength of DURAFIBER facilitates easy one-piece removal from moist wound beds and cavity wounds; minimising trauma to the wound and pain to the patient on removal.

DURAFIBER can be used in conjunction with ALLEVYN, PROFORE or PROGUIDE.

 

Ordering Information for DURAFIBER Dressings

Dressing size

Quantity

Ordering codes

5x5cm 10 66800559
10x10cm 10 66800560
15x15cm 5 66800561
2x45cm 5 66800563
4x10cm 5 66800546
4x20cm 5 66800547
4x30cm 5 66800548

Indications

DURAFIBER is indicated as an absorbent, gelling dressing for the management of chronic and acute, full thickness, partial thickness, or shallow granulating exuding wounds. For example: leg ulcers; pressure ulcers; diabetic ulcers; surgical wounds; wounds left to heal by secondary intent; donor sites; tunneling and fistulae wounds; partial thickness burns; traumatic wounds; and wounds that are prone to bleeding such as wounds that have been surgically or mechanically debrided. DURAFIBER is designed to be left in place for up to 7 days.

Precautions

Whilst DURAFIBER assists in the management of wounds prone to bleeding, it is not intended to be used as a surgical sponge in heavily bleeding wounds.

If reddening or sensitisation occurs discontinue use.

Instructions for Use

Instructions for Use

  1. Cleanse the wound according to local clinical protocol.
  2. Select the appropriate dressing size.
  3. Remove the DURAFIBER dressing from pack, using a clean technique. Cut to shape if necessary.
  4. Apply the dressing to the wound and allow for a 1cm / 1/3in. dressing overlap onto the skin surrounding the wound.
  5. When using DURAFIBER ribbon in deep cavity wounds, insert in one piece, leave at least 2.5cm / 1in. outside the wound for easy retrieval. Loosely pack deep wounds 85%, as the DURAFIBER dressing will expand to fill the wound dressing on contact with wound fluid.
  6. Secure DURAFIBER with a moisture retentive dressing (e.g. ALLEVYN) or other appropriate secondary retention.
  7. The dressing may adhere if used on lightly exuding wounds. If the dressing is not easily removed, moisten or soak the dressing to assist removal and avoid disruption of the healing wound.
  8. If DURAFIBER is used on infected wounds, the infection should be treated according to local clinical protocols.

 

Frequency of Dressing Change 

During the early stages of wound management, DURAFIBER dressings should be inspected frequently. Dressings can be left undisturbed for up to 7 days or changed when clinically indicated, (e.g. if leakage, excessive bleeding is present). Local clinical protocol should also be taken into consideration.

DURAFIBER is a single use only product. If used on more than one patient, cross contamination or infection may result. Opening the dressing pack compromises the sterile barrier therefore any unused dressing should not be retained for application at a later date.

 

Dressing Removal 

The dressing can be removed in one piece using sterile tweezers, forceps or a gloved hand. Ensure all dressings are removed.